» Articles » PMID: 16184593

Analysis of Outcome of Laparoscopic Splenectomy for Idiopathic Thrombocytopenic Purpura by Platelet Count

Overview
Journal Am J Hematol
Specialty Hematology
Date 2005 Sep 27
PMID 16184593
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Laparoscopic splenectomy (LS) is now performed routinely in patients with idiopathic thrombocytopenic purpura (ITP) refractory to the medical treatment. Low preoperative platelet count was deemed to be a contraindication for a laparoscopic approach; however, there is no data reporting the outcome in those patients. We aimed to evaluate the influence of the preoperative platelet count on the operative and postoperative course and complication rate. Retrospective cohort study that was conducted in tertiary care university-affiliated medical center and included 110 consecutive patients who underwent LS. All patients were divided into three groups by their preoperative platelet counts: <or=20 x 10(9)/L (n = 12), (20-50) x 10(9)/L (n = 18), and >50 x 10(9)/L (n = 80). The outcome and the influence of preoperative factors predictive of complications, blood transfusion, and length of stay were compared between the groups. Patients with a platelet count of <or=20 x 10(9)/L had a much longer hospital stay, received more blood transfusions, and suffered more complications than patients with platelet counts of (20-50) x 10(9)/L or higher (P < 0.05). Transfused patients had a longer hospital stay than non-transfused patients (2.08 vs. 6.4 days, P = 0.029). The strongest predictor for transfusion was the platelet count (odds ratio = 23, P = 0.008). LS in patients with very low platelet counts is feasible and reasonably safe, but the platelet count is a major determinant of morbidity. Every effort should be made to elevate platelet levels to >20 x 10(9)/L before surgery. Patients with counts >20 x 10(9)/L can safely undergo LS.

Citing Articles

Laparoscopic splenectomy in patients with idiopathic thrombocytopenic purpura and very low platelet count.

Abdollahi A, Naghibi S, Shariat Razavi H, Tavassoli A, Jabbari Nooghabi A, Jabbari Nooghabi M Caspian J Intern Med. 2022; 13(2):368-374.

PMID: 35919640 PMC: 9301219. DOI: 10.22088/cjim.13.2.8.


Laparoscopic Splenectomy for Immune Thrombocytopenic Purpura (ITP) Patients with Very Severe Thrombocytopenia.

Gupta S, Kalayarasan R, Chandrasekar S, Gnanasekaran S, Pottakkat B Indian J Hematol Blood Transfus. 2018; 34(3):535-539.

PMID: 30127567 PMC: 6081312. DOI: 10.1007/s12288-017-0902-0.


Guideline on immune thrombocytopenia in adults: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. Project guidelines: Associação Médica Brasileira - 2018.

Castro Ozelo M, Colella M, De Paula E, Nascimento A, Villaca P, Bernardo W Hematol Transfus Cell Ther. 2018; 40(1):50-74.

PMID: 30057974 PMC: 6001928. DOI: 10.1016/j.htct.2017.11.001.


Laparoscopic splenectomy for immune thrombocytopenia in patients with a very low platelet count.

Zychowicz A, Radkowiak D, Lasek A, Malczak P, Witowski J, Major P Wideochir Inne Tech Maloinwazyjne. 2018; 13(2):157-163.

PMID: 30002747 PMC: 6041578. DOI: 10.5114/wiitm.2018.75847.


Splenectomy for immune thrombocytopenia: down but not out.

Chaturvedi S, Arnold D, McCrae K Blood. 2018; 131(11):1172-1182.

PMID: 29295846 PMC: 5855018. DOI: 10.1182/blood-2017-09-742353.